Clover Health's Price Surge: A Cautionary Tale of Wall Street Optimism The latest price target boost from UBS has nearly doubled its estimate to $4. 75 for Clover Health Investments, Corp.
, sending ripples through the healthcare technology sector.
Several analysts have revised their estimates upwards in recent weeks, reflecting a growing confidence in the company's operating outlook and future growth prospects.